Clinical Trial

Predicting Appendicular Lean and Fat Mass With Bioelectrical Impedance Analysis Among Adult Patients With Obesity.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 26, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to develop and cross-validate novel bioelectrical impedance analysis (BIA) equations for predicting appendicular soft tissue masses, specifically fat mass (FM) and appendicular lean mass (ALM), in a sample of Caucasian adult subjects affected by obesity. The research will compare these new BIA equations with three established BIA-derived prediction models and validate them using dual-energy X-ray absorptiometry (DXA) and magnetic resonance imaging (MRI) data. This study utilizes existing datasets to enhance the accuracy and applicability of BIA in assessing body composition and supports the development of standardized algorithms for converting raw BIA data across different devices and populations.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-05; most recent amendment 2024-08-22.
Trial Details
NCT Number NCT06545435
Lead Sponsor University of Roma La Sapienza
Collaborators: University of Trieste, University of North Carolina, Chapel Hill, Federal University of Pelotas, Louisiana State University Health Sciences Center in New Orleans, University of Cagliari, University of Lisbon, University of Alberta, Curtin University
Conditions Obesity
Enrollment 400 participants
Start Date 2021-05-13
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-26